Abstract
Vaccination is an important epidemic intervention strategy. Resource limitations and an imperative for efficient use of public resources drives a need for optimal allocation of vaccines within a population. For a disease causing severe illness in particular members of a population, an effective strategy to reduce illness might be to vaccinate those vulnerable with a vaccine that reduces the chance of catching a disease. However, it is not clear that this is the best strategy, and it is generally unclear how the difference between various vaccine strategies changes depending on population characteristics, vaccine mechanisms and allocation objective. In this paper we develop a mathematical model to consider strategies for vaccine allocation, prior to the establishment of community transmission. By extending the SEIR model to incorporate a range of vaccine mechanisms and disease characteristics, we study the impact of vaccination on a population comprised of individuals at high and low risk of infection. We then compare the outcomes of optimal and suboptimal vaccination strategies for a range of public health objectives using numerical optimisation. Our comparison shows that the difference between vaccinating optimally and suboptimally is dependent on vaccine mechanism, diseases characteristics, and objective considered. Even when sufficient vaccine resources are available, allocation strategy remains important as allocating suboptimally could result in a worse outcome than allocating limited vaccine resources optimally. This work highlights the importance of designing effective vaccine allocation strategies, as allocation of resources can be just as crucial to the success of the overall strategy as total resources available.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
* Submitted to the editors DATE.
Data Availability
The MATLAB code used to generate all results in this manuscript is available online.
